Related Experiment Video

Updated: Apr 2, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.5K

Phosphate Metabolism in Neonates: Critical Considerations in the Perinatal Period

Pamela P Hu1, Peter J Tebben1,2

  • 1Department of Pediatrics, Section of Pediatric Diabetes, Endocrinology and Metabolism, Yale University School of Medicine, New Haven, Connecticut.

Neoreviews
|March 31, 2026
PubMed

Insights

Neonatal hypophosphatemia, a risk for premature infants, requires early evaluation. Prompt management of low phosphate levels is crucial for preventing serious health issues in newborns.

Area of Science:

  • Neonatology
  • Pediatric Nephrology
  • Biochemistry

Background:

  • Phosphate metabolism shifts significantly during the perinatal period.
  • Neonates, especially those with low birth weight, are susceptible to phosphate imbalances.
  • Disruptions in phosphate homeostasis can occur and may be overlooked.

Purpose of the Study:

  • To review the common causes of hypophosphatemia in neonates.
  • To outline the evaluation and management strategies for neonatal hypophosphatemia.
  • To highlight the importance of early detection and intervention.

Main Methods:

  • Literature review of studies on neonatal phosphate metabolism.
  • Analysis of factors contributing to hypophosphatemia in vulnerable neonates.
  • Synthesis of current guidelines for diagnosis and treatment.

Main Results:

  • Hypophosphatemia is a common complication in preterm infants.
  • Factors like prematurity and nutritional status influence phosphate levels.
  • Early identification and treatment are key to preventing adverse outcomes.

Conclusions:

  • Regular monitoring for phosphate abnormalities is essential in neonates.
  • Timely intervention can mitigate long-term complications of hypophosphatemia.
  • Understanding the causes and management is critical for neonatal care professionals.

More Related Videos

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

831
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
333
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
375
Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
18.0K
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
3.4K